Results 211 to 220 of about 102,363 (294)

How the sales of oral nicotine pouches correlate with prices and respond to taxes on cigarettes and e‐cigarettes

Addiction, EarlyView.
Abstract Background and aims Oral nicotine pouches (ONPs) have seen a dramatic rise in sales since their introduction to the US market in 2016. We aimed to define the relationship between ONP prices and sales (e.g. price elasticity of demand) and determine how taxes on cigarettes and e‐cigarettes (ECs) impact ONP sales.
Yanyun He, Zezhong Zhang, Brittney Keller‐Hamilton, Megan E. Roberts, Darren Mays, Theodore L. Wagener, Micah L. Berman, Ce Shang   +7 more
wiley   +1 more source

Higher nicotine dependence and greater smoking abstinence in parental than non-parental smokers: a secondary analysis of smoking cessation trials. [PDF]

Front Public Health
Ge Y, Li M, Luk TT, Cheung DYT, Guo N, Tong HSC, Lai VWY, Chan SSC, Wang MP, Zhao S.   +9 more
europepmc   +1 more source

5‐Methoxy‐N,N‐dimethyltryptamine (5‐MeO‐DMT) for alcohol use disorder: An open‐label, phase 2, proof‐of‐concept, clinical trial

Addiction, EarlyView.
Abstract Background and Aims Psychedelic drugs may help treat alcohol use disorder (AUD). This study evaluated BPL‐003, a novel intranasal powder formulation of 5‐methoxy‐N,N‐dimethyltryptamine (5‐MeO‐DMT) benzoate salt, in people with moderate–severe AUD enrolled in a standard of care, 10‐week programme of relapse‐prevention oriented Cognitive ...
John Marsden, Michael Kelleher, Fiona Dunbar, Anna O. Ermakova, Luke Mitcheson, Claire Roberts, James J. Rucker, Gemma Scott, Ivan Saeger, Francesca Small, Mathieu Seynaeve   +10 more
wiley   +1 more source

Nicotine Dependence in a Banned Market: Biomarker Evidence from E-Cigarette Users in São Paulo, Brazil. [PDF]

Int J Environ Res Public Health
Scholz JR, D'Amico EC, Takitane J, Sinagawa DM, Castaldelli-Maia JM, Dos Santos MF, de Oliveira RA, Marques GV, Lima EN, Rodriguez DFL, Ziotti S, Leyton V, Megid MC.   +12 more
europepmc   +1 more source

Outdated tools, underestimated harm: Modernizing cannabis surveillance in a post‐legalization era

Addiction, EarlyView.
Abstract Background Canada's 2018 legalization of non‐medical cannabis was positioned as a public health initiative, intended to shift cannabis use from criminalization to regulation. Since then, cannabis access and consumption have grown significantly but the systems used to monitor cannabis‐related harms have not kept pace.
Anees Bahji
wiley   +1 more source

Therapeutic vapes for smoking cessation and nicotine dependence. [PDF]

Aust Prescr
Cole E, Segan C, Filia S, Kyi J, Baird D.   +4 more
europepmc   +1 more source

Varenicline for cannabis use disorder: A randomized controlled trial

Addiction, EarlyView.
Abstract Background and aims Although cannabis use is widespread and prevalence of cannabis use disorder (CUD) is increasing, limited advancements have been made in CUD medication development. The objective of this study was to test the efficacy of varenicline with medical management for reducing cannabis use in treatment‐seeking individuals with CUD ...
Aimee L. McRae‐Clark, Kevin M. Gray, Nathaniel L. Baker, Brian J. Sherman, Bryan Tolliver, Jessica Burt, Alonzo Steplight, Elizabeth Chapman, Amanda Wagner   +8 more
wiley   +1 more source

Nicotine dependence, motivations, and intention to quit smoking among smoking cessation outpatients: A cross-sectional study. [PDF]

Tob Induc Dis
Chen L, Tao Z, Xu Q, Zhu Y, Ding S, Dong Y.   +5 more
europepmc   +1 more source

Neuregulin signaling pathway in smoking behavior [PDF]

, 2017
et al,, Madden, Pamela AF
core   +1 more source